Treatment of Hyperthyroidism with Heart Palpitations
Beta blockers are the first-line treatment for controlling heart palpitations in hyperthyroidism while simultaneously addressing the underlying thyroid dysfunction with antithyroid medications. 1, 2
Initial Management
Rate Control
Beta blockers - First-line therapy for controlling heart rate and palpitations
Non-dihydropyridine calcium channel blockers (e.g., diltiazem, verapamil)
- Alternative when beta blockers are contraindicated 1
Treating Underlying Hyperthyroidism
Antithyroid medications
Definitive treatment options (after initial stabilization)
Special Considerations
Atrial Fibrillation Management
- Patients with hyperthyroidism have 3-5 fold increased risk of developing atrial fibrillation, especially with TSH ≤0.1 mIU/L 2
- Treatment directed primarily toward restoring euthyroid state 1
- Antiarrhythmic drugs and cardioversion often fail until thyrotoxicosis is controlled 1
- Anticoagulation should be guided by CHA₂DS₂-VASc risk factors 1
Hemodynamic Compromise
- Prompt direct-current cardioversion is recommended for patients with AF and rapid ventricular response who are hemodynamically unstable 1
Monitoring and Follow-up
- Regular thyroid function tests to guide therapy 3
- Monitor for beta blocker dose reduction needs as patient becomes euthyroid 3
- Watch for drug interactions:
Pitfalls to Avoid
- Delayed diagnosis - Hyperthyroidism may present with minimal or atypical symptoms, especially in older patients 5
- Inadequate rate control - Failing to control heart rate can lead to tachycardia-induced cardiomyopathy 1
- Focusing only on symptom management - Treating palpitations without addressing the underlying hyperthyroidism will not resolve the condition 1
- Premature cardioversion - Attempts at rhythm control often fail until euthyroid state is achieved 1, 2
- Missing concomitant cardiac disease - Hyperthyroidism can unmask or worsen underlying cardiac conditions 1
By following this approach, both the symptomatic palpitations and the underlying hyperthyroidism can be effectively managed, reducing morbidity and improving quality of life.